We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Plus, growth stocks, rates and pricing power
Dealmakers have good economic reasons to be biased when it comes to valuing assets
Smaller companies’ weaker balance sheets exposed by ‘higher for longer’ environment
Investors tempered optimism about the sector when customers withdrew deposits more quickly than anticipated
Total addressable markets are notoriously unrealistic metrics
There are many opportunities ignored by investors chasing the Magnificent 7 stocks and AI themes
Traditional valuations may not offer quite as precise a picture of how much companies are worth
Shares rise after Danish pharma group launches anti-obesity drug Wegovy in UK
Tech leaders have driven S&P 500 higher this year but broader earnings rally is needed
While there are reasons why London is underpriced by world standards, some good opportunities stand out, says FT Alphaville
After strong first half to the year, markets are hit by concerns over interest rates and China
£2.5mn purchase drives shares up by 10 per cent
Despite years of disappointment, I’m betting on Tokyo
Find someone who loves you like GMO loves EM value
Commodity trading advisers aim to catch up after missing out
Warehouse group’s shares are down 50 per cent on their peak two years ago
Wider access to equity plans can be good for companies, and their workers
Asset allocators can’t count on long-term regional equity predictions when returns are dominated by superstar companies
Rising bond yields and nerves over US downgrade knock global equities as volatility returns
Share price has fallen 13 per cent in past three months
Not all Big Tech is the same
High inflation and interest rates remain a threat
Lenders outside US and Europe make up bulk of top 100 by market capitalisation
Company downgrades forecasts after problems in the US
Wanting more risk means doing the opposite of what I’ve always been prescribed
International Edition